PMID: 10225470May 4, 1999

Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol--a case report

T TokudomeH Matsuo


The effect of intravenous administration of disopyramide (total dose 100 mg, bolus 20 mg every 5 minutes) was compared with that of propranolol (total dose 10 mg, bolus 2 mg every 5 minutes) in a patient with hypertrophic obstructive cardiomyopathy. Left ventricular pressure gradient (LVPG) was assessed by continuous wave Doppler flowmetry. LVPG markedly decreased (97 to 16 mmHg), and preejection period (PEP) increased with an increase in heart rate (HR) during disopyramide injection. No changes were observed in LVPG and PEP, and a decrease occurred in HR during propranolol administration. These results indicate that disopyramide produced greater effects on the reduction of LVPG than propranolol, a negative inotropic agent, did.


Sep 12, 2000·Current Cardiology Reports·M V SherridA Sharma

Related Concepts

Left Ventricular Structure
Hypertrophic Cardiomyopathy
Diastolic Blood Pressure
Disopyramide, L-Tartrate, (S)-isomer
Doppler Studies
Inotropic agent
Cardiac Depressants
Idiopathic Hypertrophic Subaortic Stenosis
2D Doppler Echocardiography

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.